BACIGUENT Drug Patent Profile
✉ Email this page to a colleague
When do Baciguent patents expire, and when can generic versions of Baciguent launch?
Baciguent is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in BACIGUENT is bacitracin. There is one drug master file entry for this compound. Additional details are available on the bacitracin profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BACIGUENT?
- What are the global sales for BACIGUENT?
- What is Average Wholesale Price for BACIGUENT?
Summary for BACIGUENT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 7 |
| Clinical Trials: | 1 |
| DailyMed Link: | BACIGUENT at DailyMed |
Recent Clinical Trials for BACIGUENT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Susan Hassenbein | Phase 4 |
US Patents and Regulatory Information for BACIGUENT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | BACIGUENT | bacitracin | OINTMENT;OPHTHALMIC | 060734-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
